SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-21-023890
Filing Date
2021-09-27
Accepted
2021-09-27 17:20:21
Documents
59
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 927693
2 ex31-1.htm EX-31.1 17609
3 ex31-2.htm EX-31.2 17660
4 ex32-1.htm EX-32.1 11451
  Complete submission text file 0001493152-21-023890.txt   4436607

Data Files

Seq Description Document Type Size
5 INLINE XBRL INSTANCE DOCUMENT obmp-20201231.xml EX-101.INS 579645
6 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT obmp-20201231.xsd EX-101.SCH 47520
7 INLINE XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT obmp-20201231_cal.xml EX-101.CAL 67171
8 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT obmp-20201231_def.xml EX-101.DEF 231069
9 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT obmp-20201231_lab.xml EX-101.LAB 371630
10 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT obmp-20201231_pre.xml EX-101.PRE 298316
Mailing Address 8000 INNOVATION PARK DR, BATON ROUGE BATON ROUGE LA 70820
Business Address 8000 INNOVATION PARK DR, BATON ROUGE BATON ROUGE LA 70820 225-578-7555
THERALINK TECHNOLOGIES, INC. (Filer) CIK: 0001362703 (see all company filings)

IRS No.: 202590810 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 000-52218 | Film No.: 211282757
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences